US Patent Issued to Boehringer Ingelheim Veterinary Medicine Belgium on June 17 for "Mesenchymal stem cells for use in the treatment of atopic dermatitis" (Belgian Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,782, issued on June 17, was assigned to Boehringer Ingelheim Veterinary Medicine Belgium (Evergem, Belgium).

"Mesenchymal stem cells for use in the treatment of atopic dermatitis" was invented by Jan Spaas (Evergem, Belgium), Glenn Pauwelyn (Evergem, Belgium), Stephanie Carlier (Evergem, Belgium) and Sarah Broeckx (Evergem, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "Mesenchymal stem cells (MSCs) or a pharmaceutical composition comprising a therapeutically effective amount of MSCs can be used in the treatment of atopic dermatitis (AD) in canines and felines. In a second aspect, the MSCs or a pharmaceutical composition comprising a therape...